Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The influence of barbiturates on coumarin plasma levels and prothrombin response.

Literature DB >> 13884080

The influence of barbiturates on coumarin plasma levels and prothrombin response.

P G DAYTON, Y TARCAN, T CHENKIN, M WEINER.

Abstract

Entities: Chemical

Keywords: BARBITURATES/pharmacology; COUMARINS/blood; PROTHROMBIN TIME/pharmacology

Mesh：

Substances：

Year: 1961 PMID： 13884080 PMCID： PMC290877 DOI： 10.1172/JCI104403

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

11 in total

1. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors: A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal: J Pharmacol Exp Ther Date: 1960-09 Impact factor: 4.030

2. Effect of starvation, acenocoumarin and vitamin K on the coagulation pattern of the guinea pig.

Authors: T CHENKIN; P G DAYTON; L G WEISBERG; M WEINER
Journal: Exp Med Surg Date: 1959

3. [Interference of barbiturates in the action of tromexan].

Authors: M AVELLANEDA
Journal: Medicina (B Aires) Date: 1955-04 Impact factor: 0.653

4. [The effect of barbiturate anesthetics on the blood coagulation system; thromboelastographic findings].

Authors: C FERRARO; G GRASSI
Journal: Acta Anaesthesiol Date: 1956

5. The control of prothrombin activity with tromexan therapy.

Authors: M WEINER; G SIMSON; J J BURNS; J M STEELE; B B BRODIE
Journal: Am J Med Date: 1953-06 Impact factor: 4.965

6. The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.

Authors: S SHAPIRO; M WEINER; G SIMSON
Journal: N Engl J Med Date: 1950-11-16 Impact factor: 91.245

7. A simply prepared, standardized, and relatively stable thromboplastin extract for estimation of prothrombin time.

Authors: S SHAPIRO; M WEINER; H F LUDDECKE; R L KROC; E J WHITE
Journal: Am Heart J Date: 1950-11 Impact factor: 4.749

8. The physiological disposition of dicumarol in man.

Authors: M WEINER; S SHAPIRO; J AXELROD; J R COOPER; B B BRODIE
Journal: J Pharmacol Exp Ther Date: 1950-08 Impact factor: 4.030

9. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.

Authors: B B BRODIE; M WEINER; J J BURNS; G SIMSON; E K YALE
Journal: J Pharmacol Exp Ther Date: 1952-12 Impact factor: 4.030

10. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.

Authors: J J BURNS; M WEINER; G SIMSON; B B BRODIE
Journal: J Pharmacol Exp Ther Date: 1953-05 Impact factor: 4.030

8 in total

1. Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.

Authors: H Kopera; H Schenk; S Stulemeijer
Journal: Eur J Clin Pharmacol Date: 1978-07-30 Impact factor: 2.953

2. Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Authors: D D Breimer; A G de Boer
Journal: Eur J Clin Pharmacol Date: 1975-12-19 Impact factor: 2.953

The influence of barbiturates on coumarin plasma levels and prothrombin response.

1. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

2. Effect of starvation, acenocoumarin and vitamin K on the coagulation pattern of the guinea pig.

3. [Interference of barbiturates in the action of tromexan].

4. [The effect of barbiturate anesthetics on the blood coagulation system; thromboelastographic findings].

5. The control of prothrombin activity with tromexan therapy.

6. The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.

7. A simply prepared, standardized, and relatively stable thromboplastin extract for estimation of prothrombin time.

8. The physiological disposition of dicumarol in man.

9. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.

10. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.

1. Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.

2. Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Review 3. [Drugs interacting with coumarine oral anticoagulants (author's transl)].

4. [Changes in the velocity of drug catabolism and their importance in drug therapy].

Review 5. Clinical implications of enzyme induction and enzyme inhibition.

Review 6. Drug interactions and clinical pharmacokinetics.

7. Drug effects on dieldrin storage in rat tissue.

8. Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients.